Plenty of Bio's are trading just above cash levels so a 26m valuation post the raise still looks overpriced to me, with 2B shares on issue post this raise makes it one of the highest. Surprised there was no consolidation involved. I guess once they get to finishing a phase 2 trial the shares on issue could be 4B.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.030(2.32%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.603M | 2.014M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32871 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 2294 | 1 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |